These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7075463)

  • 1. Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.
    Vree TB; Hekster CA; van der Kleijn E
    Drug Intell Clin Pharm; 1982 Feb; 16(2):126-31. PubMed ID: 7075463
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.
    Vree TB; Hekster YA; Damsma JE; van Dalen R; Hafkenscheid JC; Friesen WT
    Ther Drug Monit; 1981; 3(2):129-35. PubMed ID: 7268825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some consequences of drug choice and dosage regimen for patients with impaired kidney function.
    Vree TB; Hekster CA; van Dalen R
    Drug Intell Clin Pharm; 1983 Apr; 17(4):267-73. PubMed ID: 6839956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose kinetics and dialyzability of oxazepam in renal insufficiency.
    Greenblatt DJ; Murray TG; Audet PR; Locniskar A; Koepke HH; Walker BR
    Nephron; 1983; 34(4):234-8. PubMed ID: 6877459
    [No Abstract]   [Full Text] [Related]  

  • 5. Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam.
    Salzman C; Shader RI; Greenblatt DJ; Harmatz JS
    Arch Gen Psychiatry; 1983 Mar; 40(3):293-7. PubMed ID: 6830408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical pharmacokinetics of diazepam and its biologically active metabolites (author's transl)].
    Klotz U
    Klin Wochenschr; 1978 Sep; 56(18):895-904. PubMed ID: 362051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the regulation of antipyrine and oxazepam metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dietary energy and protein deficiency on drug metabolism.
    Hamberg O; Ovesen L; Dorfeldt A; Loft S; Sonne J
    Eur J Clin Pharmacol; 1990; 38(6):567-70. PubMed ID: 2373130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of diazepam in dogs: transformation to oxazepam.
    Ruelius HW; Lee JM; Alburn HE
    Arch Biochem Biophys; 1965 Aug; 111(2):376-80. PubMed ID: 5861999
    [No Abstract]   [Full Text] [Related]  

  • 10. Biliary elimination of diazepam in man.
    Mahon WA; Inaba T; Umeda T; Tsutsumi E; Stone R
    Clin Pharmacol Ther; 1976 Apr; 19(4):443-50. PubMed ID: 1269195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
    Albanus L; Jönsson M; Sparf B
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetics of elimination of diazepam after intravenous injection in horses].
    Shini S; Klaus AM; Hapke HJ
    Dtsch Tierarztl Wochenschr; 1997 Jan; 104(1):22-5. PubMed ID: 9091281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatinine and drug half-lives in renal failure.
    Perrier D; Gibaldi M
    JAMA; 1972 Aug; 221(8):918. PubMed ID: 5068187
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of the biliary excretion of drugs in the human].
    Siegers CP; Klaassen CD
    Dtsch Med Wochenschr; 1983 Oct; 108(41):1564-70. PubMed ID: 6352227
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug metabolites in renal failure: pharmacokinetic and clinical implications.
    Verbeeck RK; Branch RA; Wilkinson GR
    Clin Pharmacokinet; 1981; 6(5):329-45. PubMed ID: 7037261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the conditions of absorption of determined drugs in various pharmaceutical oral forms].
    Cardini C; Stacchini A
    Boll Chim Farm; 1973 Feb; 112(2):104-9. PubMed ID: 4719965
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination half-life of drugs: value and limitations.
    Greenblatt DJ
    Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in diazepam and oxazepam.
    DeVane CL; Stewart RB
    Arch Gen Psychiatry; 1984 Mar; 41(3):311. PubMed ID: 6703851
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephro-pharmacology.
    Keller F; Ludwig U; Czock D
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):343. PubMed ID: 16961164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.